AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
Cash from Financing Activities
AFT Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Cash from Financing Activities
-NZ$7.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
BLIS Technologies Ltd
NZX:BLT
|
Cash from Financing Activities
-NZ$275k
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cannasouth Ltd
NZX:CBD
|
Cash from Financing Activities
NZ$2.1m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Rua Bioscience Ltd
NZX:RUA
|
Cash from Financing Activities
-NZ$120.4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Cash from Financing Activities
NZ$2.1m
|
CAGR 3-Years
112%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
-7.2m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Cash from Financing Activities amounts to -7.2m NZD.
What is AFT Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-80%
Over the last year, the Cash from Financing Activities growth was -80%.